Monacolin K affects lipid metabolism through SIRT1/AMPK pathway in HepG2 cells

Chia Hsin Huang, Shin Mau Shiu, Min Tze Wu, Wei Lu Chen, Shyang Guang Wang, Horng Mo Lee

研究成果: 雜誌貢獻文章

8 引文 斯高帕斯(Scopus)


Monacolin K is the secondary metabolite isolated from Monascus spp. It is the natural form of lovastatin, which is clinically used to reduce the synthesis of cholesterol by inhibiting 3-hydroxy-3-methylglutaryl coenzyme A reductase. In the present study, monacolin K increased protein expression of SIRT1 and phosphorylation level of AMP-activated protein kinase (AMPK) in HepG2 cells. Through activation of SIRT1/AMPK pathway, monacolin K increased phosphorylation of acetyl CoA carboxylase and caused nuclear translocation of forkhead box O1. The western blotting results showed that monacolin K increased expression of adipose triglyceride lipase but decreased abundances of fatty acid synthase (FAS) and sterol regulatory element-binding protein 1 (SREBP1). Monacolin K also decreased the intracellular accumulation of lipids as demonstrated by Oil Red O staining. In addition, the immunostaining showed that monacolin K prevented the nuclear translocation of SREBP1, indicating the association with down-regulation of FAS. All the demonstrated effects of monacolin K were counteracted by nicotinamide or compound C, the inhibitors of SIRT1 or AMPK. In summary, monacolin K reduces the lipid content through SIRT1/AMPK pathway in HepG2 cells, which promotes catabolism and inhibits anabolism of lipid.
頁(從 - 到)1541-1551
期刊Archives of Pharmacal Research
出版狀態已發佈 - 十二月 2013

ASJC Scopus subject areas

  • Drug Discovery
  • Molecular Medicine
  • Organic Chemistry

指紋 深入研究「Monacolin K affects lipid metabolism through SIRT1/AMPK pathway in HepG2 cells」主題。共同形成了獨特的指紋。

  • 引用此

    Huang, C. H., Shiu, S. M., Wu, M. T., Chen, W. L., Wang, S. G., & Lee, H. M. (2013). Monacolin K affects lipid metabolism through SIRT1/AMPK pathway in HepG2 cells. Archives of Pharmacal Research, 36(12), 1541-1551.